- Home
- NBIX vs DOCS Comparison
NBIX vs DOCS Comparison
Compare NBIX & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DOCS
- Stock Information
- Founded
- NBIX 1992
- DOCS 2010
- Country
- NBIX United States
- DOCS United States
- Employees
- NBIX N/A
- DOCS N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- NBIX Health Care
- DOCS Technology
- Exchange
- NBIX Nasdaq
- DOCS Nasdaq
- Market Cap
- NBIX 14.4B
- DOCS 12.3B
- IPO Year
- NBIX 1996
- DOCS 2021
- Fundamental
- Price
- NBIX $140.02
- DOCS $67.67
- Analyst Decision
- NBIX Strong Buy
- DOCS Buy
- Analyst Count
- NBIX 17
- DOCS 20
- Target Price
- NBIX $164.94
- DOCS $69.40
- AVG Volume (30 Days)
- NBIX 803.5K
- DOCS 1.3M
- Earning Date
- NBIX 10-28-2025
- DOCS 11-06-2025
- Dividend Yield
- NBIX N/A
- DOCS N/A
- EPS Growth
- NBIX 2.97
- DOCS 45.79
- EPS
- NBIX 3.39
- DOCS 1.17
- Revenue
- NBIX $2,509,900,000.00
- DOCS $589,636,000.00
- Revenue This Year
- NBIX $20.79
- DOCS $13.30
- Revenue Next Year
- NBIX $14.73
- DOCS $10.94
- P/E Ratio
- NBIX $40.99
- DOCS $57.29
- Revenue Growth
- NBIX 18.42
- DOCS 19.45
- 52 Week Low
- NBIX $84.23
- DOCS $40.87
- 52 Week High
- NBIX $154.61
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- NBIX 53.84
- DOCS 43.20
- Support Level
- NBIX $136.71
- DOCS $65.93
- Resistance Level
- NBIX $140.73
- DOCS $69.08
- Average True Range (ATR)
- NBIX 3.35
- DOCS 2.61
- MACD
- NBIX -0.34
- DOCS -0.84
- Stochastic Oscillator
- NBIX 72.66
- DOCS 18.31
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.